peoplePerson
Charu Aggarwal
Showed that adding blood-based sequencing to tissue testing finds more targetable lung cancer mutations.
Thoracic oncologist whose plasma-NGS studies changed how metastatic lung cancer is genotyped; leads immunotherapy and head-and-neck trials at Penn.
Role
Leslye M. Heisler Professor for Lung Cancer Excellence; Section Chief, Thoracic and Head & Neck Medical Oncology
Specialisms
Lung cancerLiquid biopsyImmunotherapy
Profiles
| Title | Journal | Year |
|---|---|---|
| Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer | JAMA Oncology | 2019 |